C2i Genomics and Karkinos Healthcare partner to bring AI-powered cancer detection and monitoring to India
C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India
C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India
Twist will leverage C2i’s leadership in whole-genome cancer signatures across solid cancers to generate unique synthetic reference materials for cancer detection validation in labs across the globe
Subscribe To Our Newsletter & Stay Updated